Shares of Celldex Therapeutics surged as much as 20 percent Tuesday after the Journal of Clinical Oncology published positive data from clinical trials of the company's experimental cancer vaccine, CDX-110.
Reference Articles
Celldex reports strong clinical results for cancer vaccine - (FOX Business)
Celldex Therapeutics rises on positive data (VIDEO) - (Forbes)
Celldex rallies on cancer drug data - (MarketWatch)
Celldex Therapeutics soars on data - (TheStreet.com)
Celldex surges on brain cancer drug study data - (Yahoo!Finance)
**Published in "First Word"
No comments:
Post a Comment